Genetix Biotherapeutics is a gene therapy company pursuing curative treatments to provide patients and their families with extended quality of life. The company develops and commercializes FDA-approved gene therapies for patients with progressive, debilitating, and life-shortening diseases who often have no therapeutic alternatives. Their one-time administered, potentially curative therapies are designed to deliver significant value to patients, families, the healthcare system, and society. The company operates a Market Access, Advocacy + Policy team and Patient Services programs to ensure patients can access these innovative treatments and receive comprehensive support throughout their treatment journey.
Beta · Sourced from candidate reports
Be the first to share your experience with Genetix Biotherapeutics.
Your reply helps other candidates know what to expect.